BTIS
BIO icon

BB&T Investment Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

BB&T Investment Services’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$4K Hold
16
– – ﹤0.01% 1115
2017
Q3 		$4K Hold
16
– – ﹤0.01% 954
2017
Q2 		$4K Buy
+16
New +$3.49K ﹤0.01% 910

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HCM
Hitchwood Capital Management New York $184M AUM 3.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BB&T Investment Services's BIO Position: Q4 2017 in Review

BB&T Investment Services held its Bio-Rad Laboratories Class A (BIO) position steady in Q4 2017 at 16 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1115.

BB&T Investment Services first reported a position in BIO in Q2 2017 and has held it in 3 quarters since. 302 funds tracked by Wall St. Rank hold BIO as of Q4 2017.

  • BB&T Investment Services held 16 shares of Bio-Rad Laboratories Class A worth $4K as of Q4 2017.
  • BB&T Investment Services left its Bio-Rad Laboratories Class A share count unchanged in Q4 2017.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #1115 holding.
  • BB&T Investment Services first reported a position in Bio-Rad Laboratories Class A in Q2 2017 and has held it in 3 quarters since.
  • 302 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.